A short-term increase in dietary cholesterol and fat intake affects high-density lipoprotein composition in healthy subjects

Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):575-581. doi: 10.1016/j.numecd.2018.03.005. Epub 2018 Mar 19.

Abstract

Background and aims: High-cholesterol and high-fat diets alter biochemical composition and anti-oxidant properties of high-density lipoproteins (HDL) in animals. Whether this occurs in humans is unknown. Therefore, we examined the effect of a short-term elevation in dietary cholesterol and fat intake on HDL composition in healthy subjects.

Methods and results: In a randomized, crossover clinical trial, 14 healthy young volunteers followed a 14-day low-cholesterol/low-fat diet (LChF) and a 14-day isocaloric high-cholesterol/high-fat diet (HChF) in a random order. After each diet, we measured HDL concentrations of hydroxyeicosatetraenoic acids (HETE), hydroxyoctadecadienoic acids (HODE), and haptoglobin, as well as serum amyloid A (SAA) and paroxonase-1 activity (PON-1). HDL concentrations of 15-HETE (+254%, p = 0.002), 5-HETE (+116%, p = 0.004), 13-HODE (+102%, p = 0.049), and SAA levels (+75%, p = 0.007) were significantly higher after the HChF than after the LChF. Furthermore, haptoglobin was marginally increased (+32%, p = 0.091) while PON-1 activity was unaffected (-16%, p = 0.366) by the HChF.

Conclusion: In healthy subjects, a short-term elevation in dietary cholesterol and fat intake increases HDL lipid hydroperoxide content (15-HETE, 5-HETE, 13-HODE) and SAA levels, which are key features of dysfunctional HDL. This is the first study showing that a physiologic manipulation of dietary cholesterol and fat intake affects HDL lipidome and proteome in healthy subjects independently of weight changes.

Clinical trial registration: NCT02549144.

Keywords: Cardiovascular disease; Cholesterol; High density lipoprotein; High-fat diet; Oxidized lipids; Serum amyloid A.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Cholesterol, Dietary / administration & dosage*
  • Cholesterol, Dietary / adverse effects
  • Cholesterol, Dietary / blood
  • Cross-Over Studies
  • Diet, High-Fat* / adverse effects
  • Female
  • Healthy Volunteers
  • Humans
  • Hydroxyeicosatetraenoic Acids / blood
  • Italy
  • Linoleic Acids / blood
  • Lipid Peroxides / blood*
  • Lipoproteins, HDL / blood*
  • Male
  • Postprandial Period
  • Prospective Studies
  • Serum Amyloid A Protein / metabolism
  • Time Factors
  • Young Adult

Substances

  • Biomarkers
  • Cholesterol, Dietary
  • Hydroxyeicosatetraenoic Acids
  • Linoleic Acids
  • Lipid Peroxides
  • Lipoproteins, HDL
  • Serum Amyloid A Protein
  • 5-hydroxy-6,8,11,14-eicosatetraenoic acid
  • 13-hydroxy-9,11-octadecadienoic acid
  • 15-hydroxy-5,8,11,13-eicosatetraenoic acid

Associated data

  • ClinicalTrials.gov/NCT02549144